Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,108
archived clinical trials in
Lupus

New Drug That May Protect Function of Reproductive Organs in Girls Receiving Cyclophosphamide for Lupus
Triptorelin for Ovary Protection in Childhood Onset Lupus
Status: Archived
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
New Drug That May Protect Function of Reproductive Organs in Girls Receiving Cyclophosphamide for Lupus
Triptorelin for Ovary Protection in Childhood Onset Lupus
Status: Archived
Updated: 1/1/1970
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
New Drug That May Protect Function of Reproductive Organs in Girls Receiving Cyclophosphamide for Lupus
Triptorelin for Ovary Protection in Childhood Onset Lupus
Status: Archived
Children's Hospital Central California
mi
from
Madera, CA
New Drug That May Protect Function of Reproductive Organs in Girls Receiving Cyclophosphamide for Lupus
Triptorelin for Ovary Protection in Childhood Onset Lupus
Status: Archived
Updated: 1/1/1970
Children's Hospital Central California
mi
from
Madera, CA
New Drug That May Protect Function of Reproductive Organs in Girls Receiving Cyclophosphamide for Lupus
Triptorelin for Ovary Protection in Childhood Onset Lupus
Status: Archived
Hackensack Univeristy Medical Center
mi
from
Hackensack, NJ
New Drug That May Protect Function of Reproductive Organs in Girls Receiving Cyclophosphamide for Lupus
Triptorelin for Ovary Protection in Childhood Onset Lupus
Status: Archived
Updated: 1/1/1970
Hackensack Univeristy Medical Center
mi
from
Hackensack, NJ
New Drug That May Protect Function of Reproductive Organs in Girls Receiving Cyclophosphamide for Lupus
Triptorelin for Ovary Protection in Childhood Onset Lupus
Status: Archived
Children's Hospital of New York
mi
from
New York, NY
New Drug That May Protect Function of Reproductive Organs in Girls Receiving Cyclophosphamide for Lupus
Triptorelin for Ovary Protection in Childhood Onset Lupus
Status: Archived
Updated: 1/1/1970
Children's Hospital of New York
mi
from
New York, NY
New Drug That May Protect Function of Reproductive Organs in Girls Receiving Cyclophosphamide for Lupus
Triptorelin for Ovary Protection in Childhood Onset Lupus
Status: Archived
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
New Drug That May Protect Function of Reproductive Organs in Girls Receiving Cyclophosphamide for Lupus
Triptorelin for Ovary Protection in Childhood Onset Lupus
Status: Archived
Updated: 1/1/1970
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
New Drug That May Protect Function of Reproductive Organs in Girls Receiving Cyclophosphamide for Lupus
Triptorelin for Ovary Protection in Childhood Onset Lupus
Status: Archived
Columbus Children's Research Institute
mi
from
Columbus, OH
New Drug That May Protect Function of Reproductive Organs in Girls Receiving Cyclophosphamide for Lupus
Triptorelin for Ovary Protection in Childhood Onset Lupus
Status: Archived
Updated: 1/1/1970
Columbus Children's Research Institute
mi
from
Columbus, OH
New Drug That May Protect Function of Reproductive Organs in Girls Receiving Cyclophosphamide for Lupus
Triptorelin for Ovary Protection in Childhood Onset Lupus
Status: Archived
Children's Healthcare of Atlanta at Egleston - Pediatric Cardiac Intensive Care Unit
mi
from
Atlanta, GA
New Drug That May Protect Function of Reproductive Organs in Girls Receiving Cyclophosphamide for Lupus
Triptorelin for Ovary Protection in Childhood Onset Lupus
Status: Archived
Updated: 1/1/1970
Children's Healthcare of Atlanta at Egleston - Pediatric Cardiac Intensive Care Unit
mi
from
Atlanta, GA
New Drug That May Protect Function of Reproductive Organs in Girls Receiving Cyclophosphamide for Lupus
Triptorelin for Ovary Protection in Childhood Onset Lupus
Status: Archived
Children's Hospital - Boston
mi
from
Boston, MA
New Drug That May Protect Function of Reproductive Organs in Girls Receiving Cyclophosphamide for Lupus
Triptorelin for Ovary Protection in Childhood Onset Lupus
Status: Archived
Updated: 1/1/1970
Children's Hospital - Boston
mi
from
Boston, MA
New Drug That May Protect Function of Reproductive Organs in Girls Receiving Cyclophosphamide for Lupus
Triptorelin for Ovary Protection in Childhood Onset Lupus
Status: Archived
Medical College of Wisconsin
mi
from
Milwaukee, WI
New Drug That May Protect Function of Reproductive Organs in Girls Receiving Cyclophosphamide for Lupus
Triptorelin for Ovary Protection in Childhood Onset Lupus
Status: Archived
Updated: 1/1/1970
Medical College of Wisconsin
mi
from
Milwaukee, WI
Aspirin Resistance in Systemic Lupus Erythematosus (SLE)
Status: Archived
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Aspirin Resistance in Systemic Lupus Erythematosus (SLE)
Status: Archived
Updated: 1/1/1970
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Aspirin Resistance in Systemic Lupus Erythematosus (SLE)
Status: Archived
Vanderbilt University Medical School
mi
from
Nashville, TN
Aspirin Resistance in Systemic Lupus Erythematosus (SLE)
Status: Archived
Updated: 1/1/1970
Vanderbilt University Medical School
mi
from
Nashville, TN
A Trial for Subjects With Systemic Lupus Erythematosus Who Have Completed Protocol AN-SLE3321
An Open-Label Long-term Safety Extension Trial for Subjects With Systemic Lupus Erythematosus Who Have Completed Protocol AN-SLE3321 (PEARL-SC)
Status: Archived
Clinical Trial Facility
mi
from
Santa Clara, CA
A Trial for Subjects With Systemic Lupus Erythematosus Who Have Completed Protocol AN-SLE3321
An Open-Label Long-term Safety Extension Trial for Subjects With Systemic Lupus Erythematosus Who Have Completed Protocol AN-SLE3321 (PEARL-SC)
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Santa Clara, CA
A Trial for Subjects With Systemic Lupus Erythematosus Who Have Completed Protocol AN-SLE3321
An Open-Label Long-term Safety Extension Trial for Subjects With Systemic Lupus Erythematosus Who Have Completed Protocol AN-SLE3321 (PEARL-SC)
Status: Archived
Clinical Trial Facility
mi
from
Celebration, FL
A Trial for Subjects With Systemic Lupus Erythematosus Who Have Completed Protocol AN-SLE3321
An Open-Label Long-term Safety Extension Trial for Subjects With Systemic Lupus Erythematosus Who Have Completed Protocol AN-SLE3321 (PEARL-SC)
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Celebration, FL
A Trial for Subjects With Systemic Lupus Erythematosus Who Have Completed Protocol AN-SLE3321
An Open-Label Long-term Safety Extension Trial for Subjects With Systemic Lupus Erythematosus Who Have Completed Protocol AN-SLE3321 (PEARL-SC)
Status: Archived
Clinical Trial Facility
mi
from
Detroit, MI
A Trial for Subjects With Systemic Lupus Erythematosus Who Have Completed Protocol AN-SLE3321
An Open-Label Long-term Safety Extension Trial for Subjects With Systemic Lupus Erythematosus Who Have Completed Protocol AN-SLE3321 (PEARL-SC)
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Detroit, MI
A Trial for Subjects With Systemic Lupus Erythematosus Who Have Completed Protocol AN-SLE3321
An Open-Label Long-term Safety Extension Trial for Subjects With Systemic Lupus Erythematosus Who Have Completed Protocol AN-SLE3321 (PEARL-SC)
Status: Archived
Clinical Trial Facility
mi
from
Austin, TX
A Trial for Subjects With Systemic Lupus Erythematosus Who Have Completed Protocol AN-SLE3321
An Open-Label Long-term Safety Extension Trial for Subjects With Systemic Lupus Erythematosus Who Have Completed Protocol AN-SLE3321 (PEARL-SC)
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Austin, TX
An Investigation of AGS-009 in Patients With Systemic Lupus Erythematosus (SLE)
A Randomised, Double-blind, Placebo-controlled, and Single Dose-escalation Trial of AGS-009 Administered in Subjects With Systemic Lupus Erythematosus
Status: Archived
Clinical Trial Facility
mi
from
Birmingham, AL
An Investigation of AGS-009 in Patients With Systemic Lupus Erythematosus (SLE)
A Randomised, Double-blind, Placebo-controlled, and Single Dose-escalation Trial of AGS-009 Administered in Subjects With Systemic Lupus Erythematosus
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Birmingham, AL
An Investigation of AGS-009 in Patients With Systemic Lupus Erythematosus (SLE)
A Randomised, Double-blind, Placebo-controlled, and Single Dose-escalation Trial of AGS-009 Administered in Subjects With Systemic Lupus Erythematosus
Status: Archived
Clinical Trial Facility
mi
from
Kansas City, KA
An Investigation of AGS-009 in Patients With Systemic Lupus Erythematosus (SLE)
A Randomised, Double-blind, Placebo-controlled, and Single Dose-escalation Trial of AGS-009 Administered in Subjects With Systemic Lupus Erythematosus
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Kansas City, KA
An Investigation of AGS-009 in Patients With Systemic Lupus Erythematosus (SLE)
A Randomised, Double-blind, Placebo-controlled, and Single Dose-escalation Trial of AGS-009 Administered in Subjects With Systemic Lupus Erythematosus
Status: Archived
Clinical Trial Facility
mi
from
Albany, NY
An Investigation of AGS-009 in Patients With Systemic Lupus Erythematosus (SLE)
A Randomised, Double-blind, Placebo-controlled, and Single Dose-escalation Trial of AGS-009 Administered in Subjects With Systemic Lupus Erythematosus
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Albany, NY
An Investigation of AGS-009 in Patients With Systemic Lupus Erythematosus (SLE)
A Randomised, Double-blind, Placebo-controlled, and Single Dose-escalation Trial of AGS-009 Administered in Subjects With Systemic Lupus Erythematosus
Status: Archived
Clinical Trial Facility
mi
from
Charlotte, NC
An Investigation of AGS-009 in Patients With Systemic Lupus Erythematosus (SLE)
A Randomised, Double-blind, Placebo-controlled, and Single Dose-escalation Trial of AGS-009 Administered in Subjects With Systemic Lupus Erythematosus
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Charlotte, NC
An Investigation of AGS-009 in Patients With Systemic Lupus Erythematosus (SLE)
A Randomised, Double-blind, Placebo-controlled, and Single Dose-escalation Trial of AGS-009 Administered in Subjects With Systemic Lupus Erythematosus
Status: Archived
Clinical Trial Facility
mi
from
Philadelphia, PA
An Investigation of AGS-009 in Patients With Systemic Lupus Erythematosus (SLE)
A Randomised, Double-blind, Placebo-controlled, and Single Dose-escalation Trial of AGS-009 Administered in Subjects With Systemic Lupus Erythematosus
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Philadelphia, PA
An Investigation of AGS-009 in Patients With Systemic Lupus Erythematosus (SLE)
A Randomised, Double-blind, Placebo-controlled, and Single Dose-escalation Trial of AGS-009 Administered in Subjects With Systemic Lupus Erythematosus
Status: Archived
Clinical Trial Facility
mi
from
Austin, TX
An Investigation of AGS-009 in Patients With Systemic Lupus Erythematosus (SLE)
A Randomised, Double-blind, Placebo-controlled, and Single Dose-escalation Trial of AGS-009 Administered in Subjects With Systemic Lupus Erythematosus
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Austin, TX
A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Subjects With Systemic Lupus Erythematosus or Myositis
A Phase 2 Open-label Study to Evaluate the Long-term Safety of Sifalimumab in Adult Subjects With Systemic Lupus Erythematosus or Myositis
Status: Archived
Pinnacle Research Group, LLC
mi
from
Anniston, AL
A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Subjects With Systemic Lupus Erythematosus or Myositis
A Phase 2 Open-label Study to Evaluate the Long-term Safety of Sifalimumab in Adult Subjects With Systemic Lupus Erythematosus or Myositis
Status: Archived
Updated: 1/1/1970
Pinnacle Research Group, LLC
mi
from
Anniston, AL
A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Subjects With Systemic Lupus Erythematosus or Myositis
A Phase 2 Open-label Study to Evaluate the Long-term Safety of Sifalimumab in Adult Subjects With Systemic Lupus Erythematosus or Myositis
Status: Archived
Neuromuscular Research Center
mi
from
Scottsdale, AZ
A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Subjects With Systemic Lupus Erythematosus or Myositis
A Phase 2 Open-label Study to Evaluate the Long-term Safety of Sifalimumab in Adult Subjects With Systemic Lupus Erythematosus or Myositis
Status: Archived
Updated: 1/1/1970
Neuromuscular Research Center
mi
from
Scottsdale, AZ
A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Subjects With Systemic Lupus Erythematosus or Myositis
A Phase 2 Open-label Study to Evaluate the Long-term Safety of Sifalimumab in Adult Subjects With Systemic Lupus Erythematosus or Myositis
Status: Archived
Dr. C. Michael Neuwelt, MD
mi
from
San Leandro, CA
A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Subjects With Systemic Lupus Erythematosus or Myositis
A Phase 2 Open-label Study to Evaluate the Long-term Safety of Sifalimumab in Adult Subjects With Systemic Lupus Erythematosus or Myositis
Status: Archived
Updated: 1/1/1970
Dr. C. Michael Neuwelt, MD
mi
from
San Leandro, CA
A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Subjects With Systemic Lupus Erythematosus or Myositis
A Phase 2 Open-label Study to Evaluate the Long-term Safety of Sifalimumab in Adult Subjects With Systemic Lupus Erythematosus or Myositis
Status: Archived
Inland Northwest Blood Center
mi
from
Spokane, WA
A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Subjects With Systemic Lupus Erythematosus or Myositis
A Phase 2 Open-label Study to Evaluate the Long-term Safety of Sifalimumab in Adult Subjects With Systemic Lupus Erythematosus or Myositis
Status: Archived
Updated: 1/1/1970
Inland Northwest Blood Center
mi
from
Spokane, WA
A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Subjects With Systemic Lupus Erythematosus or Myositis
A Phase 2 Open-label Study to Evaluate the Long-term Safety of Sifalimumab in Adult Subjects With Systemic Lupus Erythematosus or Myositis
Status: Archived
Arthritis Associates & Osteoporosis Center of Colorado Sprin
mi
from
Colorado Springs, CO
A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Subjects With Systemic Lupus Erythematosus or Myositis
A Phase 2 Open-label Study to Evaluate the Long-term Safety of Sifalimumab in Adult Subjects With Systemic Lupus Erythematosus or Myositis
Status: Archived
Updated: 1/1/1970
Arthritis Associates & Osteoporosis Center of Colorado Sprin
mi
from
Colorado Springs, CO
A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Subjects With Systemic Lupus Erythematosus or Myositis
A Phase 2 Open-label Study to Evaluate the Long-term Safety of Sifalimumab in Adult Subjects With Systemic Lupus Erythematosus or Myositis
Status: Archived
University of Connecticut Health Center
mi
from
Farmington, CT
A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Subjects With Systemic Lupus Erythematosus or Myositis
A Phase 2 Open-label Study to Evaluate the Long-term Safety of Sifalimumab in Adult Subjects With Systemic Lupus Erythematosus or Myositis
Status: Archived
Updated: 1/1/1970
University of Connecticut Health Center
mi
from
Farmington, CT
A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Subjects With Systemic Lupus Erythematosus or Myositis
A Phase 2 Open-label Study to Evaluate the Long-term Safety of Sifalimumab in Adult Subjects With Systemic Lupus Erythematosus or Myositis
Status: Archived
Centre for Rheumatology, Immunology & Arthritis
mi
from
Fort Lauderdale, FL
A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Subjects With Systemic Lupus Erythematosus or Myositis
A Phase 2 Open-label Study to Evaluate the Long-term Safety of Sifalimumab in Adult Subjects With Systemic Lupus Erythematosus or Myositis
Status: Archived
Updated: 1/1/1970
Centre for Rheumatology, Immunology & Arthritis
mi
from
Fort Lauderdale, FL
A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Subjects With Systemic Lupus Erythematosus or Myositis
A Phase 2 Open-label Study to Evaluate the Long-term Safety of Sifalimumab in Adult Subjects With Systemic Lupus Erythematosus or Myositis
Status: Archived
Massachusetts General Hospital
mi
from
Boston, MA
A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Subjects With Systemic Lupus Erythematosus or Myositis
A Phase 2 Open-label Study to Evaluate the Long-term Safety of Sifalimumab in Adult Subjects With Systemic Lupus Erythematosus or Myositis
Status: Archived
Updated: 1/1/1970
Massachusetts General Hospital
mi
from
Boston, MA
A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Subjects With Systemic Lupus Erythematosus or Myositis
A Phase 2 Open-label Study to Evaluate the Long-term Safety of Sifalimumab in Adult Subjects With Systemic Lupus Erythematosus or Myositis
Status: Archived
Tampa Medical Group, PA
mi
from
Tampa, FL
A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Subjects With Systemic Lupus Erythematosus or Myositis
A Phase 2 Open-label Study to Evaluate the Long-term Safety of Sifalimumab in Adult Subjects With Systemic Lupus Erythematosus or Myositis
Status: Archived
Updated: 1/1/1970
Tampa Medical Group, PA
mi
from
Tampa, FL
A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Subjects With Systemic Lupus Erythematosus or Myositis
A Phase 2 Open-label Study to Evaluate the Long-term Safety of Sifalimumab in Adult Subjects With Systemic Lupus Erythematosus or Myositis
Status: Archived
Osteoporosis And Clinical Trial Center
mi
from
Cumberland, MD
A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Subjects With Systemic Lupus Erythematosus or Myositis
A Phase 2 Open-label Study to Evaluate the Long-term Safety of Sifalimumab in Adult Subjects With Systemic Lupus Erythematosus or Myositis
Status: Archived
Updated: 1/1/1970
Osteoporosis And Clinical Trial Center
mi
from
Cumberland, MD
A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Subjects With Systemic Lupus Erythematosus or Myositis
A Phase 2 Open-label Study to Evaluate the Long-term Safety of Sifalimumab in Adult Subjects With Systemic Lupus Erythematosus or Myositis
Status: Archived
Justus Fiechtner, M. D.
mi
from
Lansing, MI
A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Subjects With Systemic Lupus Erythematosus or Myositis
A Phase 2 Open-label Study to Evaluate the Long-term Safety of Sifalimumab in Adult Subjects With Systemic Lupus Erythematosus or Myositis
Status: Archived
Updated: 1/1/1970
Justus Fiechtner, M. D.
mi
from
Lansing, MI
A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Subjects With Systemic Lupus Erythematosus or Myositis
A Phase 2 Open-label Study to Evaluate the Long-term Safety of Sifalimumab in Adult Subjects With Systemic Lupus Erythematosus or Myositis
Status: Archived
Feinstein Institute for Medical Research - North Shore - Long Island Jewish Health System
mi
from
Manhasset, NY
A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Subjects With Systemic Lupus Erythematosus or Myositis
A Phase 2 Open-label Study to Evaluate the Long-term Safety of Sifalimumab in Adult Subjects With Systemic Lupus Erythematosus or Myositis
Status: Archived
Updated: 1/1/1970
Feinstein Institute for Medical Research - North Shore - Long Island Jewish Health System
mi
from
Manhasset, NY
A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Subjects With Systemic Lupus Erythematosus or Myositis
A Phase 2 Open-label Study to Evaluate the Long-term Safety of Sifalimumab in Adult Subjects With Systemic Lupus Erythematosus or Myositis
Status: Archived
North Shore Long Island Jewish Medical Center
mi
from
New Hyde Park, NY
A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Subjects With Systemic Lupus Erythematosus or Myositis
A Phase 2 Open-label Study to Evaluate the Long-term Safety of Sifalimumab in Adult Subjects With Systemic Lupus Erythematosus or Myositis
Status: Archived
Updated: 1/1/1970
North Shore Long Island Jewish Medical Center
mi
from
New Hyde Park, NY
A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Subjects With Systemic Lupus Erythematosus or Myositis
A Phase 2 Open-label Study to Evaluate the Long-term Safety of Sifalimumab in Adult Subjects With Systemic Lupus Erythematosus or Myositis
Status: Archived
Hospital for Special Surgery
mi
from
New York, NY
A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Subjects With Systemic Lupus Erythematosus or Myositis
A Phase 2 Open-label Study to Evaluate the Long-term Safety of Sifalimumab in Adult Subjects With Systemic Lupus Erythematosus or Myositis
Status: Archived
Updated: 1/1/1970
Hospital for Special Surgery
mi
from
New York, NY
A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Subjects With Systemic Lupus Erythematosus or Myositis
A Phase 2 Open-label Study to Evaluate the Long-term Safety of Sifalimumab in Adult Subjects With Systemic Lupus Erythematosus or Myositis
Status: Archived
Box Arthritis and Rheumatology of the Carolina's
mi
from
Charlotte, NC
A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Subjects With Systemic Lupus Erythematosus or Myositis
A Phase 2 Open-label Study to Evaluate the Long-term Safety of Sifalimumab in Adult Subjects With Systemic Lupus Erythematosus or Myositis
Status: Archived
Updated: 1/1/1970
Box Arthritis and Rheumatology of the Carolina's
mi
from
Charlotte, NC
A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Subjects With Systemic Lupus Erythematosus or Myositis
A Phase 2 Open-label Study to Evaluate the Long-term Safety of Sifalimumab in Adult Subjects With Systemic Lupus Erythematosus or Myositis
Status: Archived
Cincinnati Rheumatic Disease Study Group
mi
from
Cincinnati, OH
A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Subjects With Systemic Lupus Erythematosus or Myositis
A Phase 2 Open-label Study to Evaluate the Long-term Safety of Sifalimumab in Adult Subjects With Systemic Lupus Erythematosus or Myositis
Status: Archived
Updated: 1/1/1970
Cincinnati Rheumatic Disease Study Group
mi
from
Cincinnati, OH
A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Subjects With Systemic Lupus Erythematosus or Myositis
A Phase 2 Open-label Study to Evaluate the Long-term Safety of Sifalimumab in Adult Subjects With Systemic Lupus Erythematosus or Myositis
Status: Archived
Altoona Center for Clinical Research
mi
from
, PA
A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Subjects With Systemic Lupus Erythematosus or Myositis
A Phase 2 Open-label Study to Evaluate the Long-term Safety of Sifalimumab in Adult Subjects With Systemic Lupus Erythematosus or Myositis
Status: Archived
Updated: 1/1/1970
Altoona Center for Clinical Research
mi
from
, PA
A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Subjects With Systemic Lupus Erythematosus or Myositis
A Phase 2 Open-label Study to Evaluate the Long-term Safety of Sifalimumab in Adult Subjects With Systemic Lupus Erythematosus or Myositis
Status: Archived
Columbia Arthritis Center, P.A.
mi
from
Columbia, SC
A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Subjects With Systemic Lupus Erythematosus or Myositis
A Phase 2 Open-label Study to Evaluate the Long-term Safety of Sifalimumab in Adult Subjects With Systemic Lupus Erythematosus or Myositis
Status: Archived
Updated: 1/1/1970
Columbia Arthritis Center, P.A.
mi
from
Columbia, SC
A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Subjects With Systemic Lupus Erythematosus or Myositis
A Phase 2 Open-label Study to Evaluate the Long-term Safety of Sifalimumab in Adult Subjects With Systemic Lupus Erythematosus or Myositis
Status: Archived
Houston Institute for Clinical Research
mi
from
Houston, TX
A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Subjects With Systemic Lupus Erythematosus or Myositis
A Phase 2 Open-label Study to Evaluate the Long-term Safety of Sifalimumab in Adult Subjects With Systemic Lupus Erythematosus or Myositis
Status: Archived
Updated: 1/1/1970
Houston Institute for Clinical Research
mi
from
Houston, TX
A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Subjects With Systemic Lupus Erythematosus or Myositis
A Phase 2 Open-label Study to Evaluate the Long-term Safety of Sifalimumab in Adult Subjects With Systemic Lupus Erythematosus or Myositis
Status: Archived
Rheumatic Disease Clinical Research Center
mi
from
Houston, TX
A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Subjects With Systemic Lupus Erythematosus or Myositis
A Phase 2 Open-label Study to Evaluate the Long-term Safety of Sifalimumab in Adult Subjects With Systemic Lupus Erythematosus or Myositis
Status: Archived
Updated: 1/1/1970
Rheumatic Disease Clinical Research Center
mi
from
Houston, TX
Doxycycline Outcomes in Lupus Erythematosus: (DOLE)
Doxycycline Outcomes in Lupus Erythematosus: (DOLE)
Status: Archived
Johns Hopkins University
mi
from
Baltimore, MD
Doxycycline Outcomes in Lupus Erythematosus: (DOLE)
Doxycycline Outcomes in Lupus Erythematosus: (DOLE)
Status: Archived
Updated: 1/1/1970
Johns Hopkins University
mi
from
Baltimore, MD
Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis
A Phase IIa, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability and Clinical Effect of Laquinimod in Active Lupus Nephritis Patients, in Combination With Standard of Care (Mycophenolate Mofetil and Steroids)
Status: Archived
Teva Investigational Site 04
mi
from
La Jolla, CA
Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis
A Phase IIa, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability and Clinical Effect of Laquinimod in Active Lupus Nephritis Patients, in Combination With Standard of Care (Mycophenolate Mofetil and Steroids)
Status: Archived
Updated: 1/1/1970
Teva Investigational Site 04
mi
from
La Jolla, CA
Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis
A Phase IIa, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability and Clinical Effect of Laquinimod in Active Lupus Nephritis Patients, in Combination With Standard of Care (Mycophenolate Mofetil and Steroids)
Status: Archived
Teva Investigational Site 1365
mi
from
San Leandro, CA
Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis
A Phase IIa, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability and Clinical Effect of Laquinimod in Active Lupus Nephritis Patients, in Combination With Standard of Care (Mycophenolate Mofetil and Steroids)
Status: Archived
Updated: 1/1/1970
Teva Investigational Site 1365
mi
from
San Leandro, CA
Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis
A Phase IIa, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability and Clinical Effect of Laquinimod in Active Lupus Nephritis Patients, in Combination With Standard of Care (Mycophenolate Mofetil and Steroids)
Status: Archived
Teva Investigational Site 1021
mi
from
Rochester, MN
Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis
A Phase IIa, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability and Clinical Effect of Laquinimod in Active Lupus Nephritis Patients, in Combination With Standard of Care (Mycophenolate Mofetil and Steroids)
Status: Archived
Updated: 1/1/1970
Teva Investigational Site 1021
mi
from
Rochester, MN
Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis
A Phase IIa, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability and Clinical Effect of Laquinimod in Active Lupus Nephritis Patients, in Combination With Standard of Care (Mycophenolate Mofetil and Steroids)
Status: Archived
Teva Investigational Site 1022
mi
from
Lake Success, NY
Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis
A Phase IIa, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability and Clinical Effect of Laquinimod in Active Lupus Nephritis Patients, in Combination With Standard of Care (Mycophenolate Mofetil and Steroids)
Status: Archived
Updated: 1/1/1970
Teva Investigational Site 1022
mi
from
Lake Success, NY
Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis
A Phase IIa, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability and Clinical Effect of Laquinimod in Active Lupus Nephritis Patients, in Combination With Standard of Care (Mycophenolate Mofetil and Steroids)
Status: Archived
Teva Investigational Site 1353
mi
from
Manhasset, NY
Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis
A Phase IIa, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability and Clinical Effect of Laquinimod in Active Lupus Nephritis Patients, in Combination With Standard of Care (Mycophenolate Mofetil and Steroids)
Status: Archived
Updated: 1/1/1970
Teva Investigational Site 1353
mi
from
Manhasset, NY
Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis
A Phase IIa, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability and Clinical Effect of Laquinimod in Active Lupus Nephritis Patients, in Combination With Standard of Care (Mycophenolate Mofetil and Steroids)
Status: Archived
Teva Investigational Site 1355
mi
from
New York, NY
Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis
A Phase IIa, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability and Clinical Effect of Laquinimod in Active Lupus Nephritis Patients, in Combination With Standard of Care (Mycophenolate Mofetil and Steroids)
Status: Archived
Updated: 1/1/1970
Teva Investigational Site 1355
mi
from
New York, NY
Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis
A Phase IIa, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability and Clinical Effect of Laquinimod in Active Lupus Nephritis Patients, in Combination With Standard of Care (Mycophenolate Mofetil and Steroids)
Status: Archived
Teva Investigational Site 1356
mi
from
Charlotte, NC
Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis
A Phase IIa, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability and Clinical Effect of Laquinimod in Active Lupus Nephritis Patients, in Combination With Standard of Care (Mycophenolate Mofetil and Steroids)
Status: Archived
Updated: 1/1/1970
Teva Investigational Site 1356
mi
from
Charlotte, NC
Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis
A Phase IIa, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability and Clinical Effect of Laquinimod in Active Lupus Nephritis Patients, in Combination With Standard of Care (Mycophenolate Mofetil and Steroids)
Status: Archived
Teva Investigational Site
mi
from
Columbus, OH
Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis
A Phase IIa, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability and Clinical Effect of Laquinimod in Active Lupus Nephritis Patients, in Combination With Standard of Care (Mycophenolate Mofetil and Steroids)
Status: Archived
Updated: 1/1/1970
Teva Investigational Site
mi
from
Columbus, OH